Rahul Batra,1 Ben S. Cooper,5,6 Craig Whiteley,2 Amita K. Patel,1 Duncan Wyncoll,2 and Jonathan D. Edgeworth1,3 1Directorate of Infection and 2Intensive.

Slides:



Advertisements
Similar presentations
Disclosure: nothing to disclose
Advertisements

Measuring harm in healthcare. Our demographics are changing…
Improving the quality of medical and surgical care NCEPOD Dr Marisa Mason.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Controlling MRSA Michael Gardam Director, Infection Prevention and Control University Health Network, Toronto National MRSA Intervention Lead
REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.
Current Challenges in the ICU Prof Craig Williams Institute of Healthcare Associated Infection UWS.
Outbreak Scenario S. marcescens At a multi-disciplinary meeting on the surgical unit concerns are raised regarding a possible increase in.
Bruce Gamage, RN BSN CIC Provincial Infection Control Network
Growing a New Culture: Patient Safety Nancy Brumley Gessling, MSN, CIC Infection Prevention Copper Basin Medical Center.
Evaluating Whether Interventions on the Use of Antibiotics Work to Decrease Resistance Chris Ford Regina Joice 1/18/08.
APIC Chapter 13 Journal Club April 15, 2015
Preventing Transmission of MRSA in the Hospital Setting Patricia A. Pearson RN, CIC Infection Prevention & Control Synergy / St. Joseph’s Hospital.
1 Eliminating MRSA Infections Plexus MRSA Bundle:The HOW of Staff Engagement and Culture Change.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Epidemiology and Control of Methicillin-Resistant Staphylococcus aureus in hospitals Maria Kapi,MD Registrar of Medical Microbiology Laiko General Hospital.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
 To decrease the rate of central line associated blood stream infections  To increase knowledge on the purpose and effectiveness of chlorhexidine gluconate.
Methicillin-Resistant Staphylococcus aureus (MRSA)
MRSA in Corrections Danae Bixler, MD, MPH
DECREASING HOSPITAL ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) THROUGH ACTIVE SURVEILLANCE Confidential: For Quality Improvement Purposes.
Cleaning in the ICU: strong evidence, strong convictions and a dose of reality? Cleaning in the ICU: strong evidence, strong convictions and a dose of.
Infection Prevention & Control (IPAC) at RCHT Dr Tristan Clark Infectious Diseases physicin and joint DIPC.
Simulacra & Simulation (& Health Care-Associated Infections) Michael Rubin, MD, PhD Section Chief, Epidemiology VA Salt Lake City Health Care System.
Oral Care for Patients at Risk for Ventilator-Associated Pneumonia Issued April 2010.
Nosocomial Infections in Rural Hospitals William R. Barnett Robert Bolger MEDT 401 – Issues in Health Care April 29, 2004.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
APIC Chapter 13 Journal Club March 18, 2015
A Tiered Approach to Reduce Hospital Onset C. difficile Brian Koll, MD, FACP, FIDSA Medical Director and Chief Infection Prevention and Control, BIMC.
A pilot assessment of the impact and resource implications of a 48-hour ward-based stewardship team review on antibiotic use in a tertiary centre Nicola.
1 Quality of Care – Quarterly Report Key Quality Indicators March 2008.
Understanding the Clinical Microbiology Laboratory Carol R. Quinter Ph.D. January, 2007.
Time To Regain Control Management of Multi-Drug Resistant Organisms in Healthcare Settings
Reduction of 4SICU Hospital Acquired Methicillin Resistant Staph Aureus Team Members: Infection Control Department Surgical Intensive Care Unit Staff (4SICU)
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
MRSA SCREENING: THEORETICAL VS. PRACTICAL Nancy Alfieri, March 5, 2008.
Nursing Skill Labs 1 Routine Practices and Disease Specific Precautions September 11, 2007.
Nosocomial infection Hospital acquired infections.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
MRSA (Methacillin- Resistant Staph Aureus) Deborah Moore, MS, APRN, BC VT PHS Regional Administrator.
Proposals by Paramedical Staff to Initiate Rehabilitation in Patients with Critical Illness on Mechanical Ventilation Acknowledgements This study was approved.
Nosocomial infection Hospital acquired infections.
Hot Topics in Antibiotic Management of Pediatric CF Lung Disease Mike Tracy, MD Fellow, Pediatric Pulmonary.
Is handwashing so effective? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand FRANCE ISICEM March 2009.
Acinetobacter Before we begin the investigation, we must prepare for field work. The preparation requires that we learn about the organism involved in.
1 Infectious Diseases in the Nursing Home Setting: Challenges and Opportunities for Clinical Investigation 감염내과 R2 김대호 / Prof. 이미숙 Manisha Juthani-Mehta.
How I deal with an outbreak? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand France ISICEM March 2009.
Point of Care Diagnostics for Hospital Acquired Infections (HAIs): Health Economics Perspective Detection & Identification of Infectious Agents (DIIA)
Outcomes of Carbapenem-Resistant K. pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Gopi Patel, MD; Shirish Huprikar, MD;
Understanding Epidemiology
MRSA Regina Livshits RN MSN NYU Langone Medical Center
Outbreak Investigations
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
Impact of State Reporting Laws on Central Line– Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units Hangsheng Liu, Carolyn T. A.
CRE prevalence among patients with no prior history of carriage
Hospital acquired infections
Nosocomial Infections
REDUCED RATES OF VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) COLONIZATION
The ‘bed location lottery’: the MDRO status of the prior bed occupant affects the risk of acquisition Jon Otter, PhD Scientific Director, Healthcare, Bioquell.
APIC Greater new York Chapter 13
HAI August 30, 2017.
MRSA Screen Before the Knife.
HAI January 24, 2018.
Cost utility of alternative Carbapenemase
HAI Sept. 25, 2017.
To screen or not to screen for VRE in immunocompromised patients?
Emergence of community-associated methicillin-resistant Staphylococcus aureus strains in the neonatal intensive care unit: an infection prevention and.
Overuse/Misuse of Surgical Antimicrobial Prophylaxis (SAP) in a Rural Hospital in Uganda Hiroki Saito, MD MPH;1 Kyoko Inoue, MPH;2 James Ditai, MPH;3.
Presentation transcript:

Rahul Batra,1 Ben S. Cooper,5,6 Craig Whiteley,2 Amita K. Patel,1 Duncan Wyncoll,2 and Jonathan D. Edgeworth1,3 1Directorate of Infection and 2Intensive Care Unit, Guy’s and St Thomas’ National Health Service Foundation Trust, and 3Department of Infectious Diseases, King’s College London School of Medicine at Guy’s, King’s College, and St Thomas’ Hospitals, London, and 4Center for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; and 5Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Clinical Infectious Diseases 2010; 50:210–7 Efficacy and Limitation of a Chlorhexidine-Based Decolonization Strategy in Preventing Transmission of MRSA in an Intensive Care Unit R2 조 욱 / Prof. 손준성

Introduction The mainstay of infection control –prompt identification of MRSA-colonized patients –institution of contact precautions + enforcing hand hygiene practice Guidelines recommendation –active surveillance cultures from high-risk patients :debateful –Isolation or cohorting : unclear benefit in ICU –surface antiseptics (chlorhexidine…) : benefit reported for high-risk groups ? routine cleansing of all patients ?

surface antiseptics as decolonization agents –Emerging resistance is a particular concern –MRSA resistant to mupirocin –Genes increasing MBCs to antiseptics plasmid-borne qacA/B genes code for multidrug efflux pumpsplasmid-borne qacA/B genes code for multidrug efflux pumps –2~4 X increase in MBCs for antiseptics –10%~20% of UK, 63% of European, 80% of Brazilian and 55% of Taiwanese MRSA strains Measures to control MRSA transmission in ICU –Educational campaign –Cohorting –surface antiseptic protocol

purpose To assess the effect of chlorhexidine-based antiseptic protocol during TW MRSA outbreak

Methods Clinical setting and infection control practice –two 15-bed ICUs in The St Thomas’ Hospital site –All admitted Pts ~ –contact precautions –MRSA screening swab samples nose, perineum, axilla, throat, rectal swab, other samplesnose, perineum, axilla, throat, rectal swab, other samples –intervention A : Educational campaign ( ~) –intervention B : Cohorting ( ~) –intervention C : surface antiseptic protocol ( ~) chlorhexidine gluconate  nostrils, around the mouth, tracheostomy sites, groin, axillae, and skinfoldschlorhexidine gluconate  nostrils, around the mouth, tracheostomy sites, groin, axillae, and skinfolds

Data collection and definitions –age, sex, specialty, APACHE II score, length of ICU stay, ICU mortality rate, dates of isolation of MRSA and its antibiotic resistance profile, dates of ventilation and renal replacement, and staffing levels. –Importing MRSA : MRSA cultured within 48 h after ICU admission –Acquiring MRSA : MRSA isolated for the first time after 48hrs in ICU Statistical analysis –TW and non-TW MRSA acquisition data  separate segmented regression models. –weekly number of acquisitions  Poisson models

Results

Clinical and epidemiologic characteristics Total 4570 pts admitted to ICU (for a total of 44,505 days)  517 (11%) admitted with MRSA infection, 347 of 3073 susceptible pts staying >48 h acquired MRSA antiseptic protocol appeared to be associated with an immediate reduction in acquisition of non-TW, but not TW strains no apparent effect after the educational campaign or cohorting

Weekly No. of ICU admissions and acquisitions of TW and non-TW strains

Table 1. Clinical and Microbiological Characteristics of Pts Admitted to ICU before and after Antiseptic Protocol

Estimating the impact of interventions on transmission of MRSA. Table 2. Estimated Parameters from the Poisson Segmented Regression Applied to the Non-TW and TW MRSA Data

Table 4.Chlorhexidine and Triclosan Minimum Bactericidal Concentrations (MBCs) for Selected TW and Non-TW MRSA Acquisition Isolates Table 3. Estimated Bayesian Model-Averaged Incidence Rate Ratios (IRRs) for TW and Non-TW MRSA Acquisitions

Table 4.Chlorhexidine and Triclosan Minimum Bactericidal Concentrations (MBCs) for Selected TW and Non-TW MRSA Acquisition Isolates Anatomical sites of MRSA isolation.

Discussion Chlorhexidine surface antiseptic protocol into an ICU where MRSA prevalence is stable at ∼ 20% can lead to an immediate and sustained reduction in transmission of susceptible MRSA stains. Although basic infection control interventions were already in place and actively reenforced, this does not mean that a more sustained and effective campaign would not have had an effect comparable to that of the antiseptic protocol. However, the data contribute to a body of evidence indicating that use of antiseptics, either as part of a decolonization strategy for known MRSA- colonized patients or administered to all ICU patients can be useful in controlling MRSA surface antiseptics have only limited efficacy at eradicating MRSA in multisite-colonized patients  prompting systematic reviews suppression of colonization can reduce MRSA transmission

One concern about the use of antiseptics is the lack of effect on and, therefore, selection of resistant strains The TW strains – –carried qacA/B genes, demonstrated 3-fold increased chlorhexidine MBCs in vitro – –not affected in anatomical site colonization or transmissibility after introduction of the antiseptic protocol – –all models provided evidence that the antiseptic protocol increased transmission of TW MRSA – –MBC of TW MRSA, still well below the chlorhexidine concentrations used, greater activity and/or expression of qacA/B on body surface localized TW MRSA and, therefore, a higher MBC in vivo than in vitro. ineffective application or inactivation on skin, less likely

When prevalence of qacA/B is high – –  cautions against widespread use of chlorhexidine Hand hygiene or cohorting may have reduced TW MRSA acquisitions – –may be an artefact because the exponential increase in TW MRSA is clearly not sustainable in a small ICU. A better assessment of the effect of interventions on transmission of MRSA in small units – –individual-level data within a mechanistic transmission model to account for the fact that, as the numbers colonized increase fewer patients remain at risk. hospital MRSA strains can differ in their virulence and response to infection control interventions storage and analysis of MRSA strains identified in intervention studies may help to develop a more targeted approach to enhanced infection control measures.

Conclusion antiseptic protocol caused an immediate reduction in transmission of non-TW MRSA and moderate evidence of an immediate increase in transmission of TW MRSA.